For­mer No­var­tis phar­ma­ceu­ti­cals chief David Ep­stein is go­ing biotech

David Ep­stein is join­ing a long line­up of ex­ecs who are ex­chang­ing Big Phar­ma ti­tles for a promi­nent place in the biotech world. The for­mer No­var­tis phar­ma­ceu­ti­cals chief is join­ing the biotech VC Flag­ship Pi­o­neer­ing as an ex­ec­u­tive part­ner, a new role at the trend­set­ting ven­ture group.

Ep­stein’s first role as biotech en­tre­pre­neur will in­volve tak­ing the chair­man’s job at Ru­bius Ther­a­peu­tics. And he’ll be play­ing an ac­tive role in Flag­ship’s oth­er in­vest­ments, which con­cen­trate heav­i­ly on the ax­is of aca­d­e­m­ic re­search and clin­i­cal work.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER